Folefac Aminkeng
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Diabetes and associated disorders, Pharmacogenetics and Drug Metabolism, Childhood Cancer Survivors' Quality of Life, Chemotherapy-induced cardiotoxicity and mitigation
Most-Cited Works
- → A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer(2015)270 cited
- → Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity(2016)230 cited
- → Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the Literature(2022)104 cited
- → Unbiased Profiling of Isogenic Huntington Disease hPSC-Derived CNS and Peripheral Cells Reveals Strong Cell-Type Specificity of CAG Length Effects(2019)91 cited
- → The emerging era of pharmacogenomics: current successes, future potential, and challenges(2014)76 cited
- → Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control Study(2021)75 cited
- → The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population(2018)69 cited
- → Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients(2017)57 cited
- → Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer(2017)49 cited
- → Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis(2018)39 cited